The Global next-generation biomanufacturing market will emerge the market value owing to advancement in technology and rising environmental concerns. The Global next-generation biomanufacturing market will emerge with a healthy CAGR in the forecast period from 2020-2027. A rising environmental concern, pollution level, water shortage, and seamless services in the manufacturing of medicine will fuel the market demand for the global biomanufacturing market.
The next-generation biomanufacturing market use to reduce cost and use disposable tools in the equipment to reduce pollution. In addition to it, it improves agility, flexibility, and speed of production. With the help of next-generation biomanufacturing, the construction cost reduced to half, and the quality of medicines will also improve.
Moreover, with the help of technology advancement and government investment in various medicines, plants to adopt next-generation biomanufacturing will enhance the demand for the market share. Also, the single-use product approach adoption will help in focusing on cost-saving, reducing the contamination of the product, and improved the flexibility will give rise to the demand for the use of biomanufacturing in the next generation.
Workflow and Product Overview in the Global next-generation biomanufacturing Market
Based on the workflow and product, the global next-generation biomanufacturing market segmented into Continuous Upstream Biomanufacturing, Single-Use Upstream Biomanufacturing, Downstream Biomanufacturing. The single-use upstream biomanufacturing segment has captured the highest market value in the global next-generation biomanufacturing in the forecast period from 2020-2027. The single-use upstream biomanufacturer helps the new and most rapid technology that helps in reducing cost, use disposable equipment in the plant. Thus, it improves the manufacturing of the medicines and also improves flexibility in a multi-product facility and reduces risk. Moreover, the rising single-use biomanufacturing demand is bolstering owing to the reduction in risk of manufacturing, and less contamination and wastage of resources improves the environment.
Application Overview in the Global next-generation biomanufacturing Market
Based on the Application, the global next-generation biomanufacturing market classified into Monoclonal Antibodies, Hormones, Vaccines, Recombinant Proteins, Others. The recombinant protein segment has dominated the demand of the global next-generation biomanufacturing market. Gene sequence design and optimization can significantly increase protein expression and even allow insoluble proteins to achieve soluble expression. Organisms that express proteins are also called host cells. The recombinant protein use for the production of recombinant DNA technology that involves the enclosure of DNA encoding the protein into bacteria or mammal cells to provide therapy by purifying the cells from the protein in them.
Region Overview in the Global next-generation biomanufacturing Market
Based on geography, the global next-generation biomanufacturing segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. The North America region is going to dominate the market growth of the next-generation biomanufacturing in the global market in the forecast period from 2020-2027. It is owing to the advanced biomanufacturing techniques that design to provide seamless production—moreover, people working towards the safety of the environment, and reducing cost and utilizing resources. Also, the government and other manufacturers investing in next-generation biomanufacturing will help in bolstering the demand for biomanufacturing in the future as well.
Global next-generation biomanufacturing Market: Competitive Landscape
Companies such as Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Eppendorf AG, Sartorius AG, GEA Group Aktiengesellschaft, bbi-biotech GmbH, Esco Group of Companies, Pierre Guérin, Solaris Biotechnology Srl., PBS Biotech, Inc., ZETA GmbH, Applikon Biotechnology BV, Meissner Filtration Products, Inc., and Shanghai Bailun Biotechnology Co. Ltd among others are key players in the global next-generation biomanufacturing market.
1. Research Strategic Development
1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation
2. Research Methodology
2.1. Identification of Target Market
2.2. Data Acquisition
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation
3. Executive Summary
4. Market Insights
4.1. Economic Factor Analysis
4.1.1. Drivers
4.1.2. Trends
4.1.3. Opportunities
4.1.4. Challenges
4.2. Competitors & Product Analysis
4.3. Regulatory Framework
4.4. Company market share analysis, 2019
4.5. Porter’s Five forces analysis
4.6. New Investment Analysis
4.7. PESTEL Analysis
5. Global Next Generation Biomanufacturing Market Overview
5.1. Market Size & Forecast, 2016-2027
5.1.1. Demand
5.1.1.1. By Value (USD Million)
5.2. Market Share & Forecast, 2016-2027
5.2.1. By Work flow and Product
5.2.1.1. Continuous Upstream Biomanufacturing
5.2.1.1.1. Bioreactors/Fermenters
5.2.1.1.2. Cell Culture Products
5.2.1.1.3. Filtration Systems
5.2.1.1.4. Bags & Containers
5.2.1.1.5. Mixing System
5.2.1.1.6. Sterilizers
5.2.1.1.7. Biosafety Cabinets
5.2.1.1.8. Incubators
5.2.1.1.9. Others
5.2.1.2. Single-Use Upstream Biomanufacturing
5.2.1.2.1. Single-Use Bioreactors
5.2.1.2.2. Single-Use Bags and Containers
5.2.1.2.3. Single-Use Tubing and Connectors
5.2.1.2.4. Single-Use Mixing Systems
5.2.1.2.5. Single-Use Sensors and Probes
5.2.1.3. Downstream Biomanufacturing
5.2.1.3.1. Chromatography Systems
5.2.1.3.2. Filtration Systems
5.2.1.3.3. Membrane Absorbers
5.2.1.3.4. Instruments and Accessories
5.2.1.3.5. Single-Use Equipment and Accessories
5.2.2. By Medical Application
5.2.2.1. Monoclonal Antibodies
5.2.2.2. Hormones
5.2.2.3. Vaccines
5.2.2.4. Recombinant Proteins
5.2.2.5. Others
5.2.3. By End-user
5.2.3.1. Commercial Stage
5.2.3.2. Preclinical and Development Stage
5.2.4. By Region
5.2.4.1. Europe
5.2.4.2. North America
5.2.4.3. Asia Pacific
5.2.4.4. South America
5.2.4.5. Middle East & Africa
6. Europe Next Generation Biomanufacturing Market Overview
6.1. Europe Next Generation Biomanufacturing Size & Forecast, 2016-2027
6.1.1. Demand
6.1.1.1. By Value (USD Million)
6.2. Europe Next Generation Biomanufacturing Market Share & Forecast, 2016-2027
6.2.1. By Work flow and Product
6.2.1.1. Continuous Upstream Biomanufacturing
6.2.1.1.1. Bioreactors/Fermenters
6.2.1.1.2. Cell Culture Products
6.2.1.1.3. Filtration Systems
6.2.1.1.4. Bags & Containers
6.2.1.1.5. Mixing System
6.2.1.1.6. Sterilizers
6.2.1.1.7. Biosafety Cabinets
6.2.1.1.8. Incubators
6.2.1.1.9. Others
6.2.1.2. Single-Use Upstream Biomanufacturing
6.2.1.2.1. Single-Use Bioreactors
6.2.1.2.2. Single-Use Bags and Containers
6.2.1.2.3. Single-Use Tubing and Connectors
6.2.1.2.4. Single-Use Mixing Systems
6.2.1.2.5. Single-Use Sensors and Probes
6.2.1.3. Downstream Biomanufacturing
6.2.1.3.1. Chromatography Systems
6.2.1.3.2. Filtration Systems
6.2.1.3.3. Membrane Absorbers
6.2.1.3.4. Instruments and Accessories
6.2.1.3.5. Single-Use Equipment and Accessories
6.2.2. By Medical Application
6.2.2.1. Monoclonal Antibodies
6.2.2.2. Hormones
6.2.2.3. Vaccines
6.2.2.4. Recombinant Proteins
6.2.2.5. Others
6.2.3. By End-user
6.2.3.1. Commercial Stage
6.2.3.2. Preclinical and Development Stage
6.2.4. By Country
6.2.4.1. Germany
6.2.4.2. UK
6.2.4.3. France
6.2.4.4. Italy
6.2.4.5. Rest of Europe
6.2.5. Company Market Share (Top 3-5)
6.2.6. Economic Impact Study on Europe Next Generation Biomanufacturing Market
7. North America Next Generation Biomanufacturing Market Overview
7.1. North America Next Generation Biomanufacturing Market Size & Forecast, 2016-2027
7.1.1. Demand
7.1.1.1. By Value (USD Million)
7.2. North America Next Generation Biomanufacturing Market Share & Forecast, 2016-2027
7.2.1. By Work flow and Product
7.2.1.1. Continuous Upstream Biomanufacturing
7.2.1.1.1. Bioreactors/Fermenters
7.2.1.1.2. Cell Culture Products
7.2.1.1.3. Filtration Systems
7.2.1.1.4. Bags & Containers
7.2.1.1.5. Mixing System
7.2.1.1.6. Sterilizers
7.2.1.1.7. Biosafety Cabinets
7.2.1.1.8. Incubators
7.2.1.1.9. Others
7.2.1.2. Single-Use Upstream Biomanufacturing
7.2.1.2.1. Single-Use Bioreactors
7.2.1.2.2. Single-Use Bags and Containers
7.2.1.2.3. Single-Use Tubing and Connectors
7.2.1.2.4. Single-Use Mixing Systems
7.2.1.2.5. Single-Use Sensors and Probes
7.2.1.3. Downstream Biomanufacturing
7.2.1.3.1. Chromatography Systems
7.2.1.3.2. Filtration Systems
7.2.1.3.3. Membrane Absorbers
7.2.1.3.4. Instruments and Accessories
7.2.1.3.5. Single-Use Equipment and Accessories
7.2.2. By Medical Application
7.2.2.1. Monoclonal Antibodies
7.2.2.2. Hormones
7.2.2.3. Vaccines
7.2.2.4. Recombinant Proteins
7.2.2.5. Others
7.2.3. By End-user
7.2.3.1. Commercial Stage
7.2.3.2. Preclinical and Development Stage
7.2.4. By Country
7.2.4.1. US
7.2.4.2. Canada
7.2.4.3. Mexico
7.2.5. Company Market Share (Top 3-5)
7.2.6. Economic Impact Study on North America Next Generation Biomanufacturing Market
8. Asia Pacific Next Generation Biomanufacturing Overview
8.1. Asia Pacific Next Generation Biomanufacturing Market Size & Forecast, 2016-2027
8.1.1. Demand
8.1.1.1. By Value (USD Million)
8.2. Asia Pacific Next Generation Biomanufacturing Market Share & Forecast, 2016-2027
8.2.1. By Work flow and Product
8.2.1.1. Continuous Upstream Biomanufacturing
8.2.1.1.1. Bioreactors/Fermenters
8.2.1.1.2. Cell Culture Products
8.2.1.1.3. Filtration Systems
8.2.1.1.4. Bags & Containers
8.2.1.1.5. Mixing System
8.2.1.1.6. Sterilizers
8.2.1.1.7. Biosafety Cabinets
8.2.1.1.8. Incubators
8.2.1.1.9. Others
8.2.1.2. Single-Use Upstream Biomanufacturing
8.2.1.2.1. Single-Use Bioreactors
8.2.1.2.2. Single-Use Bags and Containers
8.2.1.2.3. Single-Use Tubing and Connectors
8.2.1.2.4. Single-Use Mixing Systems
8.2.1.2.5. Single-Use Sensors and Probes
8.2.1.3. Downstream Biomanufacturing
8.2.1.3.1. Chromatography Systems
8.2.1.3.2. Filtration Systems
8.2.1.3.3. Membrane Absorbers
8.2.1.3.4. Instruments and Accessories
8.2.1.3.5. Single-Use Equipment and Accessories
8.2.2. By Medical Application
8.2.2.1. Monoclonal Antibodies
8.2.2.2. Hormones
8.2.2.3. Vaccines
8.2.2.4. Recombinant Proteins
8.2.2.5. Others
8.2.3. By End-user
8.2.3.1. Commercial Stage
8.2.3.2. Preclinical and Development Stage
8.2.4. By Country
8.2.4.1. China
8.2.4.2. India
8.2.4.3. Japan
8.2.4.4. Australia
8.2.4.5. Rest of Asia Pacific
8.2.5. Company Market Share (Top 3-5)
8.2.6. Economic Impact Study on Asia Pacific Next Generation Biomanufacturing Market
9. South America Next Generation Biomanufacturing Market Overview
9.1. South America Next Generation Biomanufacturing Market Size & Forecast, 2016-2027
9.1.1. Demand
9.1.1.1. By Value (USD Million)
9.2. South America Next Generation Biomanufacturing Market Share & Forecast, 2016-2027
9.2.1. By Work flow and Product
9.2.1.1. Continuous Upstream Biomanufacturing
9.2.1.1.1. Bioreactors/Fermenters
9.2.1.1.2. Cell Culture Products
9.2.1.1.3. Filtration Systems
9.2.1.1.4. Bags & Containers
9.2.1.1.5. Mixing System
9.2.1.1.6. Sterilizers
9.2.1.1.7. Biosafety Cabinets
9.2.1.1.8. Incubators
9.2.1.1.9. Others
9.2.1.2. Single-Use Upstream Biomanufacturing
9.2.1.2.1. Single-Use Bioreactors
9.2.1.2.2. Single-Use Bags and Containers
9.2.1.2.3. Single-Use Tubing and Connectors
9.2.1.2.4. Single-Use Mixing Systems
9.2.1.2.5. Single-Use Sensors and Probes
9.2.1.3. Downstream Biomanufacturing
9.2.1.3.1. Chromatography Systems
9.2.1.3.2. Filtration Systems
9.2.1.3.3. Membrane Absorbers
9.2.1.3.4. Instruments and Accessories
9.2.1.3.5. Single-Use Equipment and Accessories
9.2.2. By Medical Application
9.2.2.1. Monoclonal Antibodies
9.2.2.2. Hormones
9.2.2.3. Vaccines
9.2.2.4. Recombinant Proteins
9.2.2.5. Others
9.2.3. By End-user
9.2.3.1. Commercial Stage
9.2.3.2. Preclinical and Development Stage
9.2.4. By Country
9.2.4.1. Brazil
9.2.4.2. Argentina
9.2.4.3. Rest of South America
9.2.5. Company Market Share (Top 3-5)
9.2.6. Economic Impact Study on South America Next Generation Biomanufacturing Market
10. Middle East & Africa Next Generation Biomanufacturing Market Overview
10.1. Middle East & Africa Next Generation Biomanufacturing Market Size & Forecast, 2016-2027
10.1.1. Demand
10.1.1.1. By Value (USD Million)
10.2. Middle East & Africa Next Generation Biomanufacturing Market Share & Forecast, 2016-2027
10.2.1. By Work flow and Product
10.2.1.1. Continuous Upstream Biomanufacturing
10.2.1.1.1. Bioreactors/Fermenters
10.2.1.1.2. Cell Culture Products
10.2.1.1.3. Filtration Systems
10.2.1.1.4. Bags & Containers
10.2.1.1.5. Mixing System
10.2.1.1.6. Sterilizers
10.2.1.1.7. Biosafety Cabinets
10.2.1.1.8. Incubators
10.2.1.1.9. Others
10.2.1.2. Single-Use Upstream Biomanufacturing
10.2.1.2.1. Single-Use Bioreactors
10.2.1.2.2. Single-Use Bags and Containers
10.2.1.2.3. Single-Use Tubing and Connectors
10.2.1.2.4. Single-Use Mixing Systems
10.2.1.2.5. Single-Use Sensors and Probes
10.2.1.3. Downstream Biomanufacturing
10.2.1.3.1. Chromatography Systems
10.2.1.3.2. Filtration Systems
10.2.1.3.3. Membrane Absorbers
10.2.1.3.4. Instruments and Accessories
10.2.1.3.5. Single-Use Equipment and Accessories
10.2.2. By Medical Application
10.2.2.1. Monoclonal Antibodies
10.2.2.2. Hormones
10.2.2.3. Vaccines
10.2.2.4. Recombinant Proteins
10.2.2.5. Others
10.2.3. By End-user
10.2.3.1. Commercial Stage
10.2.3.2. Preclinical and Development Stage
10.2.4. By Country
10.2.4.1. Saudi Arabia
10.2.4.2. UAE
10.2.4.3. South Africa
10.2.4.4. Rest of Middle East & Africa
10.2.5. Company Market Share (Top 3-5)
10.2.6. Economic Impact Study on Middle East & Africa Next Generation Biomanufacturing Market
11. Competitor Analysis
11.1. Company Description
11.2. Financial Analysis
11.3. Key Products
11.4. Key Management Personnel
11.5. Contact Address
11.6. SWOT Analysis
11.7. Company Profile
11.7.1. Merck KGaA
11.7.2. Thermo Fisher Scientific Inc.
11.7.3. Danaher Corporation
11.7.4. Eppendorf AG
11.7.5. Sartorius AG
11.7.6. GEA Group Aktiengesellschaft
11.7.7. bbi-biotech GmbH
11.7.8. Esco Group of Companies
11.7.9. Pierre Guérin
11.7.10. Solaris Biotechnology Srl.
11.7.11. PBS Biotech, Inc.
11.7.12. ZETA GmbH
11.7.13. Applikon Biotechnology BV
11.7.14. Meissner Filtration Products, Inc.
11.7.15. Shanghai Bailun Biotechnology Co. Ltd.
11.7.16. Others prominent player.